← FDA DRUG APPROVALS

FDA ANDA · ANDA216855

NETARSUDIL MESYLATE

Sponsor: GLAND PHARMA LTD

APPLICATION
ANDA216855
TYPE
ANDA
ROUTE
DROPS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

NETARSUDIL MESYLATEPrescription
NETARSUDIL 0.02% · SOLUTION · DROPS

Approval history

2024-01-05UNKNOWN · Original · standardTA
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →